I-Elthrombopag ligama eliqhelekileyo legama lokurhweba ichiza elithi Promacta. Kwezinye iimeko, abaqeqeshi bezempilo banokusebenzisa igama lokurhweba, i-Promacta, xa bebhekisela kwigama leyeza eliqhelekileyo, eltrombopag.

Eli liyeza lisetyenziselwa ukunyanga amanqanaba aphantsi eplatelet kubantu abanesifo esithile segazi esibizwa ngokuba yi-chronic immune (idiopathic) thrombocytopenia purpura (ITP) okanye abane-hepatitis C engapheliyo. ianemia).

I-Eltrombopag isetyenziselwa ukukhusela iziqephu zokuphuma kwegazi kubantu abadala kunye nabantwana abaneminyaka eyi-1 ubudala nangaphezulu, abanesifo esingapheliyoi-immune thrombocytopenic purpura(ITP). I-ITP yimeko yokopha ebangelwa kukungabikho kweeplatelet egazini.

I-Eltrombopag ayilonyango lwe-ITP kwaye ayiyi kwenza ukuba iplatelet yakho ibale iqhelekileyo ukuba unayo le meko.

I-Eltrombopag iphinda isetyenziswe ukukhusela ukuphuma kwegazi kubantu abadala abane-hepatitis C engapheliyo abaphathwa nge-interferon (njenge-Intron A, i-Infergen, i-Pegasys, i-PegIntron, i-Rebetron, i-Redipen, okanye i-Sylatron).

I-Elthrombopag ikwasetyenziswa kunye namanye amayeza ukunyanga kakhuluanemia yeplastikikubantu abadala kunye nabantwana abaneminyaka emi-2 ubuncinane.

I-Elthrombopag ngamanye amaxesha inikezelwa emva kokuba olunye unyango aluphumelelanga.

I-Eltrombopag ayisetyenziselwa ukunyanga i-myelodysplastic syndrome (ekwabizwa ngokuba yi "preleukemia").

I-Elthrombopag ingasetyenziselwa iinjongo ezingadweliswanga kwesi sikhokelo samayeza.